ArticleTherapeutic advances in medical oncology2025
Real-world outcomes of fluorouracil-based second-line therapy in patients with advanced biliary tract cancer refractory to gemcitabine and cisplatin-based treatment.
Se Jun Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.